Natixis Co Diagnostics, Inc. Call Options Transaction History
Natixis
- $17.6 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding CODX
# of Institutions
43Shares Held
4.3MCall Options Held
48.2KPut Options Held
53.3K-
Vanguard Group Inc Valley Forge, PA1.78MShares$1.96 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny568KShares$624,4940.0% of portfolio
-
Black Rock Inc. New York, NY502KShares$552,2270.0% of portfolio
-
Geode Capital Management, LLC Boston, MA321KShares$353,4020.0% of portfolio
-
Bridgeway Capital Management, LLC Houston, TX273KShares$300,1900.01% of portfolio
About Co-Diagnostics, Inc.
- Ticker CODX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 33,781,000
- Market Cap $37.2M
- Description
- Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and ...